Since many cells of different tumor entities including lung, breast, pancreatic and colorectal overexpress HSPs and are thus more resistant to therapy including radiotherapy, efforts are being made to develop HSP inhibitors (1, 17, 18). The gene discussed is HSP90B2P; the disease is neoplasm.